Detalhe da pesquisa
1.
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.
J Infect Dis
; 219(8): 1187-1197, 2019 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407513
2.
Detecting Malaria Hotspots: A Comparison of Rapid Diagnostic Test, Microscopy, and Polymerase Chain Reaction.
J Infect Dis
; 216(9): 1091-1098, 2017 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28973672
3.
Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso.
Front Immunol
; 13: 1058227, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36532031
4.
Deep Immune Phenotyping and Single-Cell Transcriptomics Allow Identification of Circulating TRM-Like Cells Which Correlate With Liver-Stage Immunity and Vaccine-Induced Protection From Malaria.
Front Immunol
; 13: 795463, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197971
5.
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Nat Med
; 27(2): 270-278, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335323
6.
Activation-induced Markers Detect Vaccine-Specific CD4⺠T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials.
Vaccines (Basel)
; 6(3)2018 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30065162
7.
Examining human paragonimiasis as a differential diagnosis to tuberculosis in The Gambia.
BMC Res Notes
; 11(1): 31, 2018 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29334998
8.
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Nat Med
; 27(6): 1116, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021278